Clinical Trial Update: Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating a letermovir-based dual therapy for treating cytomegalovirus infections and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Letermovir (letermovir)
• PREVYMIS (letermovir)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cytomegalovirus Infection | Phase 3 | Status: RECRUITING